Salarius Pharmaceuticals
SLRX
SLRX
12 hedge funds and large institutions have $3.33M invested in Salarius Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
87% less capital invested
Capital invested by funds: $25M → $3.33M (-$21.7M)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$74.3K | |
| 2 | +$74K | |
| 3 | +$64.2K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$46K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$42K |
Top Sellers
| 1 | -$2.26M | |
| 2 | -$1.86M | |
| 3 | -$1.07M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$462K |
| 5 |
Millennium Management
New York
|
-$301K |